A recent large study describing outcome and risk factors for 175 pediatric patients who had transplants due to liver tumors in North America identified AFP decrease, low post-transplant AFP in hepatoblastoma patients and younger age in patients with HCC as factors favoring event-free survival [11]. The gene discussed is AFP; the disease is hepatocellular carcinoma.